The Street Reports

[AveragePenny]

$SHPH $NWBO GREEN PLANET MICROCAPS

Northwest Bio and Shuttle Pharmaceuticals Combo Could be the Giant Leap to New Standard of Care for Glioblastoma and Solid Tumor Cancers

https://richardacavalli.wixsite.com/greenplanetmicrocaps/trillion-dollar-cancer-treatments

[deri21]

$HRAL Hear At Last Holdings, (HRAL) Has Contracted with Canadian Heritage to Manage the Installation of Their Hohm Sales
https://www.newsfilecorp.com/release/230469

[AveragePenny]

$UTRX - Attorney Letter with Respect to Current Information - UTRX - Attorney Letter - Annual Report Period End 6/30/2024

https://www.otcmarkets.com/otcapi/company/financial-report/415387/content

[AveragePenny]

$LBRG Short Position: Could a Short Squeeze Be on the Horizon?

Article Link: https://www.ladybugnutratech.com/post/lbrg-short-position-could-a-short-squeeze-be-on-the-horizon

In the financial world, few things grab attention quite like a short squeeze. Ladybug Resource Group, Inc. (OTC PINK: LBRG), now operating as Ladybug Nutratech, could be on the verge of becoming the next headline-maker. With market makers aggressively shorting the stock for over six months, any positive momentum could force them to cover their positions potentially driving LBRG’s stock price to exciting new heights. This presents an intriguing opportunity for savvy investors.

LBRG Short Position: Could a Short Squeeze Be on the Horizon?
‍In the financial world, few things grab attention quite like a short squeeze. Ladybug Resource Group, Inc. (OTC PINK: LBRG), now operating as Ladybug Nutratech, could be on the verge of becoming the next headline-maker. With market makers aggressively shorting the stock for over six months, any positive momentum could force them to cover their positions potentially driving LBRG’s stock price to exciting new heights. This presents an intriguing opportunity for savvy investors.

‍Explore the factors fueling LBRG’s growth and position in the booming nutraceutical market, and stay ahead of trends by following our latest updates. Visit www.ladybugnutratech.com for the latest market insights and to learn how our innovative products and AI-powered solutions are reshaping wellness.

‍Understanding Short Selling
‍Short selling is a trading strategy where investors bet on a stock’s price to decline. Here’s how it works:
• Borrowing Shares: A short seller borrows shares from a broker.
• Selling at Market Price: They sell the borrowed shares at the current price.
• Buying Back to Cover: If the price drops, they buy back the shares at the lower price, return them to the lender, and pocket the difference as profit.
‍However, if the price rises instead of falling, short sellers face mounting losses. This brings us to the concept of a short squeeze.

What Is a Short Squeeze?
‍A short squeeze happens when a heavily shorted stock begins to rise unexpectedly. As the price increases, short sellers are forced to buy back shares to limit their losses, which adds upward pressure on the stock price. This creates a feedback loop where rising prices trigger more buying, leading to rapid and significant price increases.
The Situation with LBRG: Why a Short Squeeze Could Be Imminent
‍According to insights, market makers have been aggressively shorting LBRG stock for over six months. A prolonged short position suggests that many investors believe the stock’s value will decline. However, several developments indicate that LBRG’s stock could rise, potentially triggering a short squeeze.

‍1. Strong Revenue Growth:
LBRG’s recent announcement of $6 million in revenue for the first half of 2024 showcases the company’s upward momentum. This performance is driving optimism about future growth, which could attract new investors.
‍
2. Nutraceutical Market Growth:
The global nutraceuticals market is booming, expected to grow from $457.35 billion in 2024 to $976.74 billion by 2032. As LBRG continues expanding with new product lines and its NutraBuddy platform, it is well-positioned to capitalize on this trend.

‍3. Market Sentiment Shifting:
As awareness around LBRG’s growth spreads, retail investors could see this as a prime opportunity to buy. Any significant buying activity could push the price higher, putting pressure on short sellers to cover their positions.

‍4. Potential Triggers:
Market catalysts such as new partnerships, product launches, or favorable financial reports could provide the spark needed to ignite upward momentum. This would force market makers to cover their short positions, amplifying the stock’s rise.

How Short Sellers Could Be Forced to Buy Back LBRG Stock
When short positions are widespread, the potential for a short squeeze increases. If LBRG’s stock starts moving up, the short sellers would need to buy back shares to avoid further losses. The higher the price climbs, the more urgent the need to cover. This buying frenzy creates upward pressure on the stock, resulting in an explosive price rally.

A prime example of this scenario is the GameStop short squeeze in 2021, where retail investors coordinated to buy shares, driving the stock price up and forcing short sellers to cover at massive losses.
‍
Why This Is a Key Moment for LBRG Investors
Investors eyeing LBRG should pay attention to several key indicators:
• Volume Increases: A spike in trading volume could signal that momentum is building.
• Positive Announcements: New product launches or strategic partnerships could attract buyers.
• Short Interest Data: Keeping an eye on the short interest ratio (percentage of shares shorted) provides insight into how much short pressure exists.
If momentum builds, a short squeeze could provide investors with a lucrative opportunity.
However, it’s essential to remain aware of the risks—short squeezes are highly volatile events, and prices can swing wildly.
‍
What’s Next for LBRG?
LBRG’s growth trajectory, bolstered by new product lines, strategic acquisitions, and the AI-powered NutraBuddy platform, aligns perfectly with the booming nutraceutical market. With a strong foundation in place and increasing positive sentiment, market makers shorting the stock could soon be in trouble. If upward momentum takes hold, the resulting short squeeze could drive the stock price to new heights.
‍
Join the Movement, Stay Informed with Ladybug Nutratech‍
LBRG is building a strong foundation for the future with innovative products and growth initiatives. The next few weeks could be pivotal as momentum builds, presenting opportunities for investors and wellness advocates alike.

[AveragePenny]

$SHPH QUANTUM LEAP NEXT GENERATION CANCER RADIATION TREATMENT

https://richardacavalli.wixsite.com/greenplanetmicrocaps/cancer-radiation-on-steroids

Shuttle Pharmaceuticals’ Ropidoxuridine Could Substantially Increase Demand for Improved and Cost-Effective Cancer Radiation Treatments

?

National Cancer Institute supported clinical trials found iododeoxyuridine (IUdR) is a potent radiation sensitizer that could be a game changer for cancer patients undergoing radiation therapy.



Unfortunately, iododeoxyuridine is troubled by dose-limiting systemic toxicities and the need for prolonged continuous IV infusion that exposes patients to excessive infection risk.



Shuttle developed orally delivered Ropidoxuridine (IPdR) that replaces iododeoxyuridine and solves many problematic issues. Shuttle Pharmaceuticals is beginning Phase 2 clinical trial.



Management is highly experienced. A recent filing shows that the CEO, Dr. Anatoly Dritschilo stepped up with is own personal financing as the company filed an S1 suggesting a new round of finance to fund trials and operations.



Successful clinical trials of Ropidoxuridine have the potential to substantially increase demand for an already large radiation therapy market.



Shuttle Pharmaceuticals Holdings, Inc. has a market cap close to $4 million and a share price of $1.28 as of the close of October 24, 2024.

?

Radiation therapy is an $8 billion market commonly used to treat cancer, however its’ dosage is limited by the harmful effects it can have on normal healthy cells that are adjacent to the targeted cancerous cells. Limiting the dosage of radiation limits the efficacy of this treatment.

?

Investment thesis:

A safe drug that would make cancer cells more sensitive and more responsive to radiation therapy would likely be in substantial demand as it could dramatically improve the efficacy and increase the usage of radiation treatment.

?

Findings in Phase 2 clinical trial of radiation sensitizer iododeoxyuridine

The Phase 2 clinical trial found that iododeoxyuridine (IUdR), is a powerful tool to add to radiation therapy because it makes cancer cells more sensitive to the treatment of radiation.

?

Iododeoxyuridine (IUdR) is a potent radiosensitizer, however, its clinical utility is limited by dose limiting systemic toxicities and the need for prolonged continuous infusion.

?

Shuttle Pharmaceutical Holdings, Inc. (SHPH: NASD) Ropidoxuridine is a safer and more effective way to administer radiation therapy

Ropidoxuridine is a prodrug (equivalent) of IUdR that compared to IUdR, is easier to administer and less toxic with a more favorable therapeutic index in preclinical studies.

[deri21]

$HYEX Healthy Extracts Expects to Report Record Third Quarter 2024, with Net Revenue Up More than 20%
https://finance.yahoo.com/news/healthy-extracts-expects-report-record-123100936.html

[AveragePenny]

“Bitech Technologies (OTCQB: $BTTC ) The Future of Electricity Interconnection, Driving Global Energy Innovation” see stocks inside…

https://thestreetreports.com/?p=4236

Bitech Technologies has announced the launch of its new blog series on “Electricity Interconnection,” aimed at providing in-depth insights into the evolving landscape of energy connectivity. As renewable energy and distributed energy resources (DER) gain momentum globally, this series will delve into the concept of “New Electricity Interconnection” and how modern smart power technologies are reshaping traditional electricity grids.

Inline image
Historically, electricity interconnection referred to linking grids across regions, countries, or even continents, allowing for seamless energy transfer and greater grid reliability. However, today’s trends, driven by renewable energy sources like solar and wind, and advancements in energy storage, have expanded this definition. The process now encompasses the integration of distributed generation systems with existing grids, fostering energy optimization, grid stability, and the efficient flow of electricity from diverse sources.

The upcoming blog posts will break down key topics, including the role of transmission and distribution networks, power flow dynamics, and the increasing significance of after-the-meter power systems. Bitech Technologies emphasizes that this evolving interconnection framework will enhance energy sharing, increase grid reliability, and facilitate the global transition towards sustainable power systems. These developments will not only improve energy efficiency but also support the integration of renewable energy into mainstream electricity networks.

Stay tuned for the next blog in this series, which will focus on “What is New Electricity Interconnection?” providing detailed explanations of how these advancements are revolutionizing the future of energy. Read more.

Here are four additional companies under $1 demonstrating robust market trends, volume, and awareness:

· Alternus Clean Energy (NASDAQ: ALCE) is a renewable energy company focused on acquiring and operating solar parks across Europe, contributing to the global transition to sustainable power sources.

· Nature’s Miracle Holding Inc. (NASDAQ: NMHI) is a wellness company dedicated to developing and marketing innovative natural health and personal care products aimed at enhancing overall well-being.

· Virios Therapeutics Inc. (NASDAQ: VIRI) is a clinical-stage biotechnology company focused on developing novel antiviral therapies for fibromyalgia and other chronic diseases linked to viral activation.

· PetVivo Inc. (OTCQB: PETV) is a veterinary biotech company specializing in innovative treatments for companion animals, including its proprietary injectable therapy for managing osteoarthritis in pets.

These companies are actively leveraging technology in their respective sectors, showcasing market strength through their innovative products and services.

[AveragePenny]

RJD Green Inc. (OTC: RJDG) JSI Acquisition Accelerates Expansion, Projecting Major Revenue Growth more stocks inside…

https://thestreetreports.com/rjd-green-inc-otc-rjdg-acquires-jsi-interiors-driving-expansion-and-revenue-growth/

RJD Green Inc. (OTC: RJDG) announced today that its subsidiary, Silex Holdings Inc., has acquired the assets of JSI Interiors (JSI), a strategic move poised to accelerate the company’s growth. The acquisition includes JSI’s state-of-the-art fabrication system, existing contracts, purchase orders, and a well-established customer base. In 2023, the combined revenues of Silex Holdings and JSI totaled $7.8 million, and JSI will now operate as a division of Silex Holdings Inc.

Growth Projections

RJD Green’s CEO, Ron Brewer, expressed strong optimism about the future, stating, “We are excited to replicate the successful business strategies that drove Silex Interiors from $1.4 million in revenue at acquisition to $5.8 million annually. With JSI’s cutting-edge fabrication capabilities, we expect JSI Products to contribute an additional $3 million to $4 million in revenue during its first year.” Brewer highlighted the company’s expanded market reach, targeting both residential and commercial projects, with a long-term goal of reaching $10 million in annual revenue for Silex Holdings through consistent growth and operational efficiency.

RJD Green Inc. Overview

RJD Green Inc. operates as a diversified holding company, focused on acquiring and managing high-potential businesses across various sectors. The company’s divisions include the RJD Green Healthcare Services Division, which owns IOSoft Systems—a provider of advanced payment technologies and software for healthcare providers; Earthlinc Environmental Services Division, specializing in green environmental technologies; and Silex Holdings Division, focused on specialty construction and industrial services. Silex fills a niche between large retail chains and local contractors, offering high-quality granite countertops, cabinets, and related products for residential builders, commercial contractors, and DIY customers.

This acquisition strengthens RJD Green’s market position, expands its service offerings, and positions the company for accelerated revenue growth, making it an attractive opportunity for investors looking to capitalize on the company’s strong trajectory in the construction and industrial sectors.

Penny Stocks Gaining Market Attention and Driving Innovation

RJD Green Inc. (OTC: RJDG) is expanding with the acquisition of JSI Interiors, boosting revenue potential. AtlasClear Holdings, Inc. (NYSE American: ATCH) is developing a cutting-edge financial services platform for small and middle-market firms, while Seelos Therapeutics, Inc. (NASDAQ: SEEL) is advancing innovative therapies for central nervous system disorders. MicroCloud Hologram Inc. (NASDAQ: HOLO) is revolutionizing visual technology with its groundbreaking holographic solutions, and Elevai Labs Inc. (NASDAQ: ELAB) continues to lead in medical aesthetics, bolstered by a recent $8 million offering. MicroAlgo Inc. (NASDAQ: MLGO) is gaining attention in AI-driven algorithms, providing scalable solutions for big data and machine learning.

These companies are showcasing innovation and growth across various sectors, positioning themselves for future success.

[AveragePenny]

"Signing Day Sports, Inc. (NYSE American: SGN) Soars in Pre-Market on Acquisition News – see more penny stocks inside…."

Article Link: https://www.benzinga.com/pressreleases/24/09/ab40946727/signing-day-sports-inc-nyse-american-sgn-soars-in-pre-market-on-acquisition-news-see-more-penny-s

This article spotlights some of the most promising companies that are gaining traction and driving penny stock market interest, showcasing how their strategic moves are setting them up for future success.

Signing Day Sports, Inc. BIEI: is soaring after announcing a strategic acquisition of Swifty Global, a sports and casino technology company. The acquisition will allow Signing Day Sports to leverage Swifty's scalable tech and gaming licenses to enhance its product offerings and expand into new markets. This move marks a key step in its growth strategy, boosting its position in the global sports tech space.

Premier Graphene Inc. HALB: in partnership with HGI Industrial Technologies and Defense Atomics, is advancing the use of graphene in ballistic protection solutions. This collaboration has the potential to revolutionize personal and tactical equipment for military and government entities, with the partnership expected to generate over $50 million in revenue.

Freight Technologies, Inc. RJDG: recently secured a contract with Bayer AG’s BAYRY CropScience LP to provide cross-border truckload services. This win further solidifies Fr8App's position as a leader in logistics management, offering advanced tech solutions to optimize supply chains and enhance cross-border transportation efficiency for major global players.

Halberd Corporation SPZI: is making strides in brain injury and PTSD treatment through its partnership with Defense Atomics and Athena Telemedicine Partners. With funding secured for advanced research and pilot studies involving veterans, Halberd is poised to deliver cutting-edge solutions using CRISPR technology and its LDX PTSD and brain injury protocol.

RJD Green Inc.'s CBDW: diversified portfolio in healthcare, construction, and environmental services is driving impressive revenue growth. With strategic acquisitions and expanding market reach, RJDG is rapidly gaining traction in multiple high-demand sectors.

JP 3E Holdings, Inc. SPZI: has successfully completed its first shipment of 500 metric tons of Aluminum Ingot through its Trade Finance platform in collaboration with Bloxcross. This milestone highlights the company's growing presence in the global commodities market, positioning it for further expansion and success in the fast-moving aluminum sector.

1606 Corp. CBDW is acquiring a strategic stake in Adnexus Biotechnologies, a leader in AI-driven drug discovery. This partnership integrates Adnexus's advanced AI platform, SUTRA, into 1606's portfolio, enabling the development of breakthrough treatments for infectious and neurological diseases. The collaboration strengthens 1606 Corp.'s commitment to revolutionizing healthcare through AI innovation

[AveragePenny]

$DDDX 3D PRINTING FINALLY READY FOR PREDICTED EXPLOSIVE GROWTH

Article Link: https://richardacavalli.wixsite.com/greenplanetmicrocaps/3d-printing-to-explode
AI CHAT GPT CONFIRMS DORMANT 3D PRINTING STOCKS MAY NOW BE READY FOR EXPLOSIVE GROWTH
Several years ago, 3D Printing stocks started out with a bang but then fizzled . . . Now AI ChatGPT tells us that 3D printing stocks are about to explode
Lower-cost additive manufacturing, major advancements in materials, greater precision, and faster production are now making 3D printing a better choice for manufacturing and point to robust growth for the near and the long term
In-depth searching for potential investment opportunities in the 3D printing sector revealed several promising companies, but one in particular stands out as undervalued, under-followed, and positioned for exceptional growth 
3DX Industries is one of only two or three companies that are selling under $1/share and are down from over 30 cents in 2021 to a current price of just under 2 cents with a total market cap of under $2 million

One of 3DX Industries Advanced 3D Printers
ChatGPT has proven to be a very powerful AI tool and is rapidly providing users with far more useful information than ever available with only Google searches.
We asked ChatGPT, “Is the future for 3D printing explosive?” and we got the following reply:
“Yes, the future for 3D printing is often described as "explosive" due to its rapidly growing impact across various industries and its potential to revolutionize traditional practices. Here's why:
Technological Advancements: The field of 3D printing is advancing quickly, with new materials, faster printing speeds, and more precise technologies continually emerging. This rapid evolution makes it a highly dynamic and transformative area.
2.Diverse Applications: From medical implants and prosthetics to aerospace parts and architectural models, the versatility of 3D printing is leading to groundbreaking applications. The technology's ability to create complex, customized objects is expanding its use across numerous fields.
Economic Impact: 3D printing is poised to disrupt traditional manufacturing by enabling more cost-effective, on-demand production. This shift could reduce the need for large inventories, lower production costs, and streamline supply chains.
Personalization and Customization: The technology allows for high levels of customization, which is increasingly demanded by consumers. This capability can lead to personalized products in sectors like healthcare, fashion, and consumer goods.
Sustainability: 3D printing has the potential to reduce waste by using only the material needed to build an object. This can lead to more sustainable manufacturing practices and lower environmental impact.
Innovation in Materials: Research is continuously expanding the range of materials that can be used in 3D printing, including metals, ceramics, and even biological materials. This opens up new possibilities for applications and industries.
The combination of these factors creates a scenario where the impact of 3D printing could be transformative on a global scale, leading many to view its future as not just promising but truly explosive in terms of potential and disruption.
Of course, investing in stocks always involves risks, and it’s essential to conduct thorough research and consider both the potential rewards and risks before making investment decisions.”
After seeing this compelling response from ChatGPT, we examined a number of promising 3D printing stocks and discovered 3DX Industries, Inc. (DDDX: OTC) that stood out from the pack far enough that we now work with them to help tell their story to investors interested in the 3D printing space.
We were looking for a company that offers the following criteria:
Proven and experienced management
Advanced printers in well-equipped factory with potential for large sales
Previously provided products for big name entities that would welcome future whale-sized orders when the company is ready to deliver
Early sales with potential for exponential growth
Small market cap and small number of outstanding shares
Under followed and undervalued.
After reviewing over a dozen 3D printing companies, 3DX Industries, Inc. stood out because it met all of our target criteria and with the promise for impressive growth in the relatively near future.  We believe shares are underfollowed and undervalued.
Following is a list as of September 12, 2024, of several competing and excellent investment candidates in the 3D printing sector, however, 3DX Industries emerges as our top choice for percentage growth after reviewing the industry:
NNDM – Nano Dimension - $2.15 per share - $471 million market cap
SYSS – Stratasys - $6.77 per share - $481 million market cap
XMTR – Xometry - $17.32 per share - $853 million market cap
DDD – 3D Systems - $2.19 per share -$292 million market cap
PTC – PTC - $167.80 per share - $20.3 billion market cap
DASTY – Dassault Systemes - $39.56 per share - $51.7 billion
PRLB – Proto Labs - $29.18 per share - $733.8 million market cap
MTLS – Materialise - $5.05 per share - $298 million market cap
DM – Desktop Metal - $4.48 per share - $149 million market cap
MKFG – Market Forged - $.1961 per share - $39.8 million market cap
VLD – Velo3D - $1.28 per share - $11 million marker cap
ONVO – Organovo - $.55 per share - $8.4 million market cap
Why 3DX?
To assure accurate information, we point to the current Investor Presentation Deck for 3DX.  Following are slides from that deck that describe the business, their technology, their clients, the market for 3D printing, and the growth potential for 3DX Industries.  Each slide tells a very important story in a succinct manner.

[AveragePenny]

“2024 Penny Stocks to Watch: ADHC, BTTC, RJDG, VHAI, CBDW Poised for Major Growth”

https://thestreetreports.com/2024-penny-stocks-to-watch-adhc-bttc-rjdg-vhai-cbdw-poised-for-major-growth/

These five companies Under five cents are driving innovation and growth across diverse sectors, positioning themselves for substantial shareholder value and long-term success.

Correction: On Wednesday September 11, 2024, it was reported American Diversified Holdings Corporation (OTC: ADHC) has acquired GlucoGuard which was incorrect. It should have been reported as follows: American Diversified Holdings Corporation (OTC: ADHC) is acquiring GlucoGuard, an AI-driven device for managing nocturnal hypoglycemia in diabetic patients. Developed by Zachary Smith, the device offers non-invasive glucose monitoring and delivery. Smith will join ADHC as a Scientific Advisor, positioning GlucoGuard to tap into the $28 billion U.S. diabetes market.

Bitech Technologies Corporation (OTCQB: BTTC) is a prominent independent power provider specializing in Battery Energy Storage Systems (BESS) to stabilize the grid and create sustainable revenue streams. The company’s expertise in renewable energy and smart energy solutions, including microgrids and Energy Management Systems (EMS), is supported by a skilled team with a strong industry impact. With a strategic portfolio of 1.965 GW in BESS projects and 1.4 GW in solar, Bitech is focusing on its BESS business, projecting significant growth as U.S. energy demand rises. Technological innovation, financial strength, and key partnerships position the company for rapid expansion in the clean energy sector.

RJD Green Inc.’s (OTC: RJDG) Silex Holdings Division has appointed Mark Gould as the new Division Manager. Gould brings a strong background in sales, marketing, and management within the construction products sector, having led a wholesale company that grew ten-fold during his six-year tenure. Under his leadership, the division will enhance offerings like cabinetry, doors, wood flooring, fireplaces, and hardware. CEO Ron Brewer expressed confidence in Gould’s ability to drive growth and add new revenue streams for Silex.

Vocodia Holdings Corp. (OTC: VHAI), an AI software company specializing in practical AI solutions, has provided an update on its progress and strategic path forward. The company has significantly reduced its cash burn rate from over $1 million to less than $300,000, improving financial health and operational efficiency. Vocodia is converting pilot programs into long-term contracts, validating its DISA technology platform, which enhances customer service solutions.

1606 Corp. (OTC: CBDW) plans to acquire a strategic stake in Adnexus, a leader in AI-driven drug discovery and infectious disease research, enhancing its presence in AI-powered healthcare solutions. This partnership is set to accelerate innovation, particularly in developing treatments for diseases like HIV and SARS-CoV-2 using advanced AI technology. With the global AI market projected to reach $2.25 trillion by 2030, this collaboration positions 1606 Corp. to capitalize on the rapid growth in AI and healthcare, driving shareholder value and establishing both companies as pioneers in their respective fields.

With cutting-edge advancements across diverse industries, these companies are setting new standards for innovation and growth. As they strengthen their market positions and expand their technological capabilities, American Diversified Holdings Corporation (OTC: ADHC), Bitech Technologies (OTCQB: BTTC), RJD Green Inc. (OTC: RJDG), Vocodia Holdings Corp. (OTC: VHAI) and 1606 Corp. (OTC: CBDW) are poised to deliver shareholder value and drive long-term success in their respective sectors.

[AveragePenny]

Peraso Inc. (NASDAQ: PRSO) Technology, Paradigm Shift, Breakthroughs, Expansion, Key Developments, Financial Outlook – Watch Now!

https://thestreetreports.com/peraso-inc-nasdaq-prso-technology-paradigm-shift-breakthroughs-expansion-key-developments-financial-outlook-watch-now/

Key Developments in July

Peraso Inc. (NASDAQ: PRSO), a global leader in mmWave technology for 60 GHz unlicensed and 5G licensed networks, announced a significant breakthrough in July. Tachyon Networks decided to expand its antenna kits to enhance the TNA-303X 60 GHz terminal, powered by Peraso’s X720 chipsets and mmWave Perspectus modulus. These kits operate in the license-free 60 GHz band, addressing the rising demand for reliable broadband solutions. Tachyon’s products are key components of the growing WISPs (Wireless Internet Service Providers) market, connecting users to Wi-Fi via specific access points.

Sector Impact

Management believes they are creating a paradigm shift in the wireless industry, affecting multiple sectors including telecommunications, mobile devices, security systems, smart home technology, and industrial automation. Enhanced connectivity and performance in these areas will drive significant advancements and efficiencies across these diverse applications.

Insights from Leadership

CEO Ron Glibbery and CFO Jim Sullivan recently discussed Peraso’s progress in an Alpha Wolf interview. They highlighted Peraso’s advancements in wireless technology and the company’s major customer, Ubiquity, a leading OEM. The CEO emphasized the anticipated continued demand for Peraso’s technology from service providers utilizing Ubiquity products. Watch the entire interview now!

Stock Performance and Market Analysis

On July 29, Zacks released a research report highlighting Peraso’s strong stock momentum, noting a 9.3% gain over 12 weeks and a beta of 1.82. The report also pointed out the stock’s attractive valuation, with a price-to-sales ratio of only 0.36, indicating a bargain for investors. Read entire news article now!

Financial Results Announcement

Peraso will announce its fiscal second-quarter financial results on August 12, 2024, after market close. A conference call will follow at 1:30 PM Pacific Time, available live on the Peraso corporate website.

Other Companies in these sector(s) to watch now:

Here are four public companies under $10 in the mentioned sectors showing strong market trends and awareness: Inseego Corp. (NASDAQ: INSG), Sonim Technologies Inc. (NASDAQ: SONM), A10 Networks, Inc. (NYSE: ATEN), iRobot Corporation (NASDAQ: IRBT). These companies are actively involved in their respective sectors, demonstrating market trends and awareness through their innovative products and services.

[AveragePenny]

Monkey Rock Group Inc. (OTC: MKRO) Expands Global Presence with Strategic Acquisitions


https://thestreetreports.com/monkey-rock-group-inc-otc-mkro-expands-global-presence-with-strategic-acquisitions/

Monkey Rock Group Inc. (OTC: MKRO), a US-based corporation, announces the acquisition of FGL GLOBAL LOGISTICA LTDA and C-FREIGHT AGENCIAMENTOS INTERNACIONAIS LTDA. These strategic acquisitions, finalized on July 22, 2024, through its subsidiary Global United Logistic and managed by Sviluppo Dati S.r.l., are set to boost Monkey Rock’s global presence and business strategy, generating combined annual revenues exceeding €56 million.

The newly acquired companies generate a combined revenue of approximately €56 million with an EBITDA margin of 34.1%, substantially boosting Monkey Rock’s financial performance and market position.

Monkey Rock aims to enhance production processes by integrating digitalization across all operations, leveraging Sviluppo Dati’s expertise. Additionally, the company is committed to ecological transition, focusing on transforming traditional logistics and transportation into green, zero-emission solutions, aligning with global sustainability goals.

Giuseppe Esposito, President of Monkey Rock Group, stated, “We are pleased to announce these strategic acquisitions. They underscore our commitment to growth and global presence, demonstrating MKRO’s readiness to establish its independent identity while driving innovation and sustainability in the logistics sector.”

Monkey Rock Group Inc. (OTC: MKRO), a company based in Italy within the European Union. It operates in the overnight and general freight shipping sector, competing with industry giants like FedEx Corporation (NYSE: FDX), United Parcel Service (NYSE: UPS), Alibaba Group Holding Limited (NYSE: BABA), Amazon.com, Inc. (NASDAQ: AMZN), CSX Corporation (NASDAQ: CSX), Union Pacific Corporation (NYSE: UNP), among others. Monkey Rock’s workforce has over 1900 employees, overseeing 70 plants. Notably, the company achieved annual consolidated revenues amounting to $285 million, Read more.

[AveragePenny]

$BSEG Big Screen Entertainment Group: Revolutionizing Film Production with AI

Article Link: https://richardacavalli.wixsite.com/greenplanetmicrocaps/about-1-1

Our treasure chest is filled with inspiring young companies that have innovative solutions to address a clean, low-carbon environment and to provide disruptive technologies to make life better

3 Cent BSEG Using AI to Create Moderate Budget Movies with Potential Blockbuster Revenues

Harnessing the Power of AI:

AI-Driven Content Creation: Big Screen Entertainment Group is leading the way in utilizing AI to create moderate budget films with mass appeal, leveraging AI projections to boost sales and profits.

Script to Sales Analysis: Our cutting-edge AI technology analyzes every aspect of a film or TV project, from script development to sales forecasts, ensuring high ROI potential.

Audience Engagement Predictions: AI predicts audience engagement and success, even for indie films, helping prioritize projects with the highest revenue potential.

Cost and Time Efficiency: AI accelerates and reduces the cost of development and production without compromising creative instincts, aiding informed decision-making throughout the process.

Optimized Distribution Strategies: AI establishes patterns based on previous releases to optimize distribution strategies, increasing revenue and sales for investors and productions.

Content Analysis and Financial Forecasts: Our platform offers comprehensive content analysis, financial forecasting, character & casting analysis, and packaging tools, enhancing the creative process while ensuring the human touch remains the final determinant.

[AveragePenny]

5 Stocks in the News to Watch Now: LGVN, PRSO, SIRI, INBS, VTAK


https://www.marketscreener.com/quote/stock/LONGEVERON-INC-118907392/news/5-Stocks-in-the-News-to-Watch-Now-LGVN-PRSO-SIRI-INBS-VTAK-47432541/

Longeveron Inc. (NASDAQ: LGVN) announced in July 2024 that the FDA granted Fast Track designation for its cellular therapy, Lomecel-B(TM), aimed at treating mild Alzheimer's Disease, accelerating its clinical development. The therapy also received RMAT designation, and the company announced a $9 million registered direct offering managed by H.C. Wainwright & Co.

Peraso Inc. (NASDAQ: PRSO) a leader in mmWave technology for 5G and 60 GHz networks, announced preliminary Q2 revenues of approximately $4.2 million, ending June 30, 2024, exceeding prior guidance. This represents a 50% sequential and 70% year-on-year growth. The stock has been trending upward, with investors anticipating it may rise above the 200 DMA and potentially challenge its three-month high of $2.04.

SiriusXM (NASDAQ: SIRI) reported year-on-year revenues at $2.16 billion, beating analysts' forecasts by 1.4%. The stock has surged from a multiyear low in the past month, likely due to a short squeeze ahead of its anticipated merger with Liberty Sirius XM Holdings, Read more.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) announced in July 2024, 3 new UK major manufacturers, have adopted its "Fingerprint Drug Screening System" for fast, reliable drug detection from fingertip sweat. Additionally, the system's successful biocompatibility testing advances it toward FDA 510(k) clearance, aiming for US market entry in 2025.

Catheter Precision (NYSE American: VTAK) implemented a new share structure on July 15, 2024, ensuring equal impact on shareholders. The company received evaluations and orders for its LockeT product from institutions such as UCLA Ronald Reagan Medical Center and HCA Healthcare. Their expansion strategy involves first introducing LockeT products to establish credibility, followed by the rollout of VIVO products. Additionally, the patient follow-up phase for the VIVO European Registry concluded in June 2023.

[AveragePenny]

Catheter Precision Inc. (NYSE American: VTAK) Moves Forward with Aggressive Expansion Strategy and New Share Structure

https://thestreetreports.com/catheter-precision-inc-nyse-american-vtak-moves-forward-with-aggressive-expansion-strategy-and-new-share-structure/

Catheter Precision Inc. (NYSE American: VTAK) is pushing forward with an aggressive expansion strategy, recently reflected in the acceptance of its new share structure by the capital markets. The company implemented a 1-for-10 reverse stock split of its common stock on July 15, 2024. This restructuring ensures all shareholders are equally affected without altering their ownership percentages.

Product Evaluations and Purchase Orders

As part of its expansion plan, Catheter Precision announced product evaluations and received purchase orders for its innovative LockeT product from prominent healthcare institutions, including UCLA Ronald Reagan Medical Center, Eisenhower Medical Center in California, Rady’s Children’s Hospital, and HCA Healthcare (NYSE: HCA). HCA Healthcare, a significant player in the healthcare industry, generated $64 billion in revenue in 2023.

Strategic Expansion Plan

Catheter Precision’s strategic expansion plan involves a two-step approach:

Introduction of LockeT Products: The company aims to first introduce its LockeT products into renowned healthcare institutions. This initial focus on leading medical centers is designed to establish a solid foundation and build credibility within the healthcare community. The innovative design and efficacy of the LockeT products serve as the entry point for Catheter Precision into these prestigious institutions.
Rollout of VIVO Products: Once the LockeT products are well-established and have gained the trust and acceptance of healthcare professionals, Catheter Precision plans to roll out its VIVO products. This phased approach ensures the company leverages the initial success of the LockeT products to facilitate the adoption of VIVO products, which may require a more significant integration effort due to their advanced technology and application.
By following this two-step strategy, Catheter Precision aims to create a seamless transition and adoption process for its innovative medical devices. The ultimate goal is to enhance patient care and outcomes by providing healthcare institutions with a comprehensive suite of cutting-edge products that address various medical needs. This strategic expansion not only strengthens Catheter Precision’s market position but also underscores its commitment to advancing medical technology and improving healthcare delivery.

Strengthening the Sales Team

To support its expansion efforts, Catheter Precision has made significant changes to its sales team. The company appointed Marie-Claude Jacques as the new Chief Commercial Officer, emphasizing boosting the sales of both LockeT and VIVO products. This move is part of a broader effort to expand the business development team and drive growth in the competitive medical device market.

Strengthening the Sales Team

To support its expansion efforts, Catheter Precision has made significant changes to its sales team by appointing Marie-Claude Jacques as the new Chief Commercial Officer. She, along with the newly joined sales team, previously drove Baylis Medical’s sales from approximately $10 million to $100 million before its acquisition by Boston Scientific Corporation (NYSE: BSX) for $1.75 billion. Read entire release. This strategic move aims to boost sales of LockeT and VIVO products and is part of a broader initiative to expand the business development team and drive growth in the competitive medical device market.

Here are additional companies in the healthcare sector: Teladoc Health Inc. (NYSE: TDOC), Alphatec Holdings Inc. (NASDAQ: ATEC), Ocular Therapeutix Inc. (NASDAQ: OCUL), and Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) offering diverse opportunities across healthcare, pharmaceuticals, and diagnostics, making them attractive options for investors interested in the healthcare sector.

[AveragePenny]

Peraso Inc. (NASDAQ: PRSO) Upward Stock Trend Amid Strong Q2 Revenue Projections and Recent Milestones

https://thestreetreports.com/peraso-inc-nasdaq-prso-sees-upward-stock-trend-amid-strong-q2-revenue-projections-and-recent-milestones/

Peraso Inc. (NASDAQ: PRSO), a global leader in mmWave technology for 5G licensed and 60 GHz unlicensed networks, has seen its stock trend upward recently. On July 16, the company announced preliminary revenues of approximately $4.2 million for the second fiscal quarter ending June 30, 2024, surpassing the previous guidance of $3.7 million to $4 million. This reflects a sequential growth of 50% and a year-on-year growth of 70%, driven by strategic developments and product innovations.

On Tuesday, July 16, 2024, Peraso Inc. (NASDAQ: PRSO), a global leader in mmWave technology for 5G licensed and 60 GHz unlicensed networks, saw its stock close slightly down, despite trading at 7.22 times its normal volume. The stock ended the day at $1.53, just below its 200-day moving average (DMA) of $1.56.

Investors are closely watching Peraso’s stock performance, anticipating a trendline that could rise above the 200 DMA. Such a movement could bring the stock back into breakout territory, potentially challenging its three-month high of $2.04.

Peraso’s stock activity comes amid a backdrop of significant company developments, including strong second-quarter revenue projections and strategic product innovations. The market is keenly aware of Peraso’s potential for growth and stability, given its recent performance and advancements in mmWave technology. As the company continues to leverage its technological edge and expand its market presence, investors remain optimistic about its future prospects.

In April, Peraso revealed that its X710 chip has been incorporated by Panasonic Corporation (Tokyo: 6752.T) (OTC: PCRFF) into system networks throughout Japan for its 60 GHz WLAN solution. This product features Peraso’s phased array antenna technology, delivering low latency and high-speed communication over distances similar to wired LANs, thus boosting its market attractiveness.

Additionally, in the second quarter, Peraso received a significant purchase order of $2.88 million in April, representing incremental last-time buys related to the company’s previous end-of-life (EOL) programs for its memory integrated circuit products. Up to that point, Peraso had booked EOL purchase orders totaling around $16.9 million, though the majority remained in backlog.

The company’s strong performance continued from the first fiscal quarter, where it generated total net revenues of $2.8 million, up from $1.8 million in the previous quarter. Product revenues for the quarter stood at $2.7 million, compared to $1.5 million in the prior quarter.

These developments highlight Peraso’s strategic growth and technological advancements, solidifying its position as a leader in the mmWave technology sector and attracting significant investor attention.

Here are additional companies in the technology semiconductor and communications equipment sectors: United Microelectronics (NYSE: UMC), AXT, Inc. (NASDAQ: AXTI), Valens Semiconductor Ltd. (NYSE: VLN), and Getty Images Holdings, Inc. (NYSE: GETY). These companies offer diverse opportunities and present attractive options for investors interested in this industry and its sectors.